AAT α-antitrypsin AMPH Amphetamine ApoA1 Apolipoprotein A1 ApoB Apolipoprotein B1 ASO Antistreptolysin O BARB Barbiturates BENZ Benzodiazapines C3 Complement C3 6.7 99 AAT/HPT PV FS Pack 2 (Saline dilution) 1 Urine 2.5 26 EDTA 30.00 450.00 mg/dl 0.30 4.50 g/l DAT PV FS Pack 4 100 1450 ng/ml 100 1450 μg/l 6.7 21 ApoA1 PV FS Pack 1 30.00 240.00 mg/dl 0.30 2.40 g/l 6.7 22 ApoB PV FS Pack 1 35.00 300.00 mg/dl 0.35 3.00 g/l 2.7 28 FS1 Urine 6.0 26 Urine 6.0 26 ASO/RF PV Isotonic saline 25 900 IU/mL 25 900 kiu/l (kiu/l = IU/mL x 1) DAT PV FS Pack 4 60 800 ng/ml 60 800 μg/l DAT PV FS Pack 4 85 800 ng/ml 85 800 μg/l 16.7 20 Protein PV FS Pack 2 40 380 mg/dl 400 3800 mg/l 88.0 183 mg/dl 0.88 1.83 g/l 340 3 28 days Cutoff 500 ng/ml Negative: <500 ng/ml Positive: 500 ng/ml Cutoff 1000 ng/ml Negative: <1000 ng/ml Positive: 1000 ng/ml 101 215 mg/dl 1.01 2.15 g/l 340 3 51 132 mg/dl 0.51 1.32 g/l 340 3 Adult: Children: Cutoff 200 ng/ml Negative: <200 ng/ml Positive: 200 ng/ml Cutoff 200 ng/ml Negative: <200 ng/ml Positive: 200 ng/ml 200 IU/mL 240 IU/mL Positive: 300 ng/ml Positive: 300 ng/ml 575 3 21 days 340 3 88 165 mg/dl 880 1650 mg/l 340 3 Ortho-Clinical Diagnostics, Inc., 2017 VITROS is a registered trademark of Ortho-Clinical Diagnostics, Inc. 100 Indigo Creek Drive Rochester, NY 14626 1
C4 Complement C4 CAFFN Caffeine (includes calibrators) COCM Cocaine Metabolites dldl Direct LDLC dtibc Direct Total Iron- Binding Capacity EDTA Urine 9.0 26 16.7 20 Protein PV FS Pack 2 8.0 60.0 mg/dl 80.0 600.0 mg/l 2 15 TDM PV FS Pack 3 1.00 30.00 μg/ml 5.15 154.50 μmol/l μmol/l = μg/ml x 5.15) 2.7 19, FS1 DAT PV FS Pack 4 50 1000 ng/ml 50 1000 μg/l PV FS Pack 2 30 350 mg/dl 0.78 9.05 mmol/l (mmol/l = mg/dl x 0.02586) 12 29 dtibc PV FS Pack 2 60 650 μg/dl 10.7 116.4 μmol/l (μmol/l = μg/dl x 0.179) 14 44 mg/dl 140 440 mg/l 340 3 Therapeutic: 8 20 μg/ml Toxic: >50 μg/ml Cutoff 150 ng/ml Negative: <150 ng/ml Positive: 150 ng/ml Optimal: <100 mg/dl Near to above Optimal: 100 129 mg/dl Borderline High: 130-159 mg/dl High: 160 189 mg/dl Very High: 190mg/dL Male: 261 462 μg/dl Female: 265 497 μg/dl 41 103 μmol/l >258 μmol/l Positive: 300 ng/ml <2.59 mmol/l 2.59 3.35 mmol/l 3.36 4.12 mmol/l 4.13 4.90 mmol/l 4.91 mmol/l 46.8 82.7 μmol/l 47.4 89.0 μmol/l 340 3 28 days 3 4 600 3 660 3 28 days Ortho-Clinical Diagnostics, Inc., 2017 VITROS is a registered trademark of Ortho-Clinical Diagnostics, Inc. 100 Indigo Creek Drive Rochester, NY 14626 2
GENT Gentamicin HbA1c Direct % Glycated Hemoglobin HCY 2 Homocysteine HPT Haptoglobin hscrp High-Sensitivity C-Reactive Protein IgA Immunoglobulin A IgG Immunoglobulin G EDTA EDTA Whole blood EDTA EDTA EDTA 3 13 TDM PV FS Pack 2 0.60 10.00 μg/ml 1.30 21.60 μmol/l 2.16) HbA1c: 5 Hb: 5 31 %A1c PV Isotonic saline 4 14 %A1c NGSP 20 130 HbA1c (mmol/mol) Therapeutic Trough: <1.00 μg/ml <2.00 μg/ml Toxic Trough: 2.00 μg/ml Therapeutic Peak: 5.00 8.00 μg/ml 8.00 12.00 μg/ml Toxic Peak: >12.00 μg/ml 6.5 %A1c NGSP 48 Calculated HbA1c (mmol/mol) SI Units 15 27 HCY 2 PV FS Pack 2 2.0 50.0 μmol/l Male: Female: 6.7 99 AAT/HPT PV 16 17 FS1 FS Pack 2 20.00 300.00 mg/dl 0.20 3.00 g/l hscrp PV Do not dilute 0.10 15.00 mg/l Low: Average: High: Indeterminant: 6.7 20 Protein PV FS Pack 2 40.00 800.00 mg/dl 0.40 8.00 g/l 6.7 20 Protein PV FS Pack 2 270.00 2700.00 mg/dl 2.70 27.00 g/l <2.16 μmol/l <4.32 μmol/l 4.32 μmol/l 10.80 17.28 μmol/l 17.28 25.92 μmol/l >25.92 μmol/l Action Suggested Action Suggested 6.6 14.8 μmol/l 4.7 12.6 μmol/l 1 week Hb- A1c: 340 3 28 days Hb: 340/ 700 340 3 28 days 30 200 mg/dl 0.30 2.00 g/l 340 3 14 days <1.0 mg/l 1.0 to 3.0 mg/l >3.0 10.0 mg/l >10.0 mg/l 660 3 70 400 mg/dl 0.70 4.00 g/l 340 3 700 1600 mg/dl 7.00 16.00 g/l 340 3 Ortho-Clinical Diagnostics, Inc., 2017 VITROS is a registered trademark of Ortho-Clinical Diagnostics, Inc. 100 Indigo Creek Drive Rochester, NY 14626 3
IgM Immunoglobulin M malb Micro Albumin METD Methadone OP Opiates PALB Prealbumin PCP Phencyclidine EDTA 6.7 20 Protein PV FS Pack 2 25.00 400.00 mg/dl 0.25 4.00 g/l Urine 12 24 malb PV FS Pack 2 0.6 19.0 mg/dl 6.0 190.0 mg/l Urine 4 26 DAT PV FS Pack 4 40 735 ng/ml 40 735 μg/l Urine OP-LO 8 OP-HI 2 Urine 5 26 26 DAT PV FS Pack 4 OP-LO: 100 900 ng/ml (μg/l) OP-HI: 700 4000 ng/ml (μg/l) 16.7 23 PALB PV FS Pack 2 3.0 46.0 mg/dl 30 460 mg/l DAT PV FS Pack 4 6.0 72.0 ng/ml 6.0 72.0 μg/l 40 230 mg/dl 0.40 2.30 g/l 340 3 Cutoff 150 ng/ml Negative: <150 ng/ml Positive: 150 ng/ml (OP-LO) Positive: 300 ng/ml <1.7 mg/dl <16.7 mg/l 340 3 Positive: 300 ng/ml Cutoff 2000 ng/ml (OP-HI) Negative: <2000 ng/ml Positive: 2000 ng/ml 1 week 340 3 28 days 17.6 36.0 mg/dl 176.4 360.1 mg/l 340 3 Cutoff 25 ng/ml Negative: <25 ng/ml Positive: 25 ng/ml RF Rheumatoid Factor THC Cannabinoids EDTA 5 16 Urine 6 30 ASO/RF PV FS Pack 2 8.6 120.0 IU/mL 8.6 120.0 klu/l (klu/l = IU/mL x 1) DAT PV FS Pack 4 5.0 80.0 ng/ml 5.0 80.0 μg/l Cutoff 20 ng/ml Negative: <20 ng/ml Positive: 20 ng/ml <12 IU/mL <12 klu/l 575 3 Cutoff 50 ng/ml Negative: <50 ng/ml Positive: 50 ng/ml 340 3 28 days Ortho-Clinical Diagnostics, Inc., 2017 VITROS is a registered trademark of Ortho-Clinical Diagnostics, Inc. 100 Indigo Creek Drive Rochester, NY 14626 4
Reaction Sample TOBRA Tobramycin EDTA 3 14 TDM PV FS Pack 2 0.60 10.00 μg/ml 1.28 21.40 μmol/l 2.14) Therapeutic Trough: <1.00 μg/ml <2.00 μg/ml Toxic Trough: 2.00 μg/ml Therapeutic Peak: 5.00 8.00 μg/ml 8.00 12.00 μg/ml Toxic Peak: >12.00 μg/ml <2.14 μmol/l <4.28 μmol/l 4.28 μmol/l 10.70 17.12 μmol/l 17.12 25.68 μmol/l >25.68 μmol/l 3 weeks TRFRN Transferrin VALP Valproic acid VANC Vancomycin EDTA EDTA EDTA 4.8 20 Protein PV FS Pack 2 80.00 750.00 mg/dl 0.80 7.50 g/l 3 12 TDM PV FS Pack 2 10.0 150.0 μg/ml 69.3 1039.5 μmol/l 6.93) 3 11 TDM PV FS Pack 2 5.00 50.00 μg/ml 3.35 33.50 μmol/l 0.67) 206 381 mg/dl 2.1 3.8 g/l 340 3 Minimal: 50.0 μg/ml Therapeutic: 50.0 120.0 μg/ml Possible Toxic: >100.0 μg/ml Serious Toxic: >200.0 μg/ml Therapeutic Trough: 5.00-10.00 μg/ml Toxic Peak: 40.00 μg/ml 346.5 μmol/l 346.5-831.6 μmol/l >693.0 μmol/l >1386.0 μmol/l 3.35-6.70 μmol/l 26.80 μmol/l 1 week 340 3 7 days Ortho-Clinical Diagnostics, Inc., 2017 VITROS is a registered trademark of Ortho-Clinical Diagnostics, Inc. 100 Indigo Creek Drive Rochester, NY 14626 5
Ortho-Clinical Diagnostics, Inc., 2017 VITROS is a registered trademark of Ortho-Clinical Diagnostics, Inc. 100 Indigo Creek Drive Rochester, NY 14626 6